Actuate Therapeutics Inc (ACTU) quarterly cash flow statement — complete operating, investing & financing history
| Cash from Operations | -5.02M | -3.74M | -6.68M | -4.35M | -4.62M | -4.77M | -9.15M | -2.67M | -5.25M | -5.51M | -5.36M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -8.63% | 21.72% | 27.01% | -62.66% | 11.98% | 13.42% | - | - | - | - | - |
| Net Income | -5.63M | -4.55M | -5.41M | -5.95M | -6.32M | -6.45M | -5.97M | -6.57M | -8.3M | -7.61M | -5.27M |
| Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock-Based Compensation | 1.36M | 1.54M | 1.8M | 0 | 1.13M | 1.19M | 565.98K | 90.02K | 148.21K | 122.05K | 0 |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 143.56K | 5.06K | 5.06K | 1.41M | 5.06K | 5.08K | 658.73K | 1.15M | 537.59K | 56.66K | 96.48K |
| Working Capital Changes | -891.53K | -728.83K | -3.08M | 191.31K | 568.12K | 477.01K | -4.4M | 2.66M | 2.36M | 1.92M | -185.07K |
| Change in Receivables | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | -322.8K | 185.56K | -1.83M | 507.95K | 622.16K | -302.9K | -3.61M | 1.93M | 483.7K | 864.68K | 468.68K |
| Cash from Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Expenditures | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Financing | -8.09K | -29.3K | 17.11M | 6.95M | -133.48K | -109.41K | 22.32M | 957.04K | 4.36M | 0 | 2.46M |
| Debt Issued (Net) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1M | 4.5M | 0 | 0 |
| Equity Issued (Net) | 519.62K | 0 | 17.21M | 6.95M | -133.48K | -109.41K | 23.96M | 0 | 0 | 0 | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -527.72K | -29.3K | -98.3K | 0 | 0 | 0 | -1.64M | -42.96K | -142.77K | 0 | 0 |
| Net Change in Cash | -5.03M | -3.77M | 10.43M | 2.6M | -4.75M | -4.88M | 13.17M | -1.72M | -890.35K | -5.51M | 0 |
| Free Cash Flow | -5.02M | -3.74M | -6.68M | -4.35M | -4.62M | -4.77M | -9.15M | -2.67M | -5.25M | -5.51M | -5.36M |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -8.63% | 21.72% | 27.01% | -62.66% | 11.98% | 13.42% | - | - | - | - | - |
| FCF per Share | -0.21 | -0.16 | -0.31 | -0.22 | -0.24 | -0.24 | -0.47 | -0.14 | -0.34 | -0.36 | -0.40 |
| FCF Conversion (FCF/Net Income) | 0.89x | 0.82x | 1.23x | 0.73x | 0.73x | 0.74x | 1.53x | 0.41x | 0.63x | 0.72x | 1.02x |
| Interest Paid | 0 | 0 | 70.96K | 0 | 0 | 0 | 71.03K | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 800 | 0 | 0 | 0 | 0 |